Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles
Open Access
- 24 February 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 21803
Abstract
The therapeutic potential of antibodies has not been fully exploited as they fail to cross cell membrane. In this article, we have tested the possibility of using plant virus based nanoparticles for intracellular delivery of antibodies. For this purpose,Sesbania mosaic viruscoat protein (CP) was genetically engineered with the B domain ofStaphylococcus aureusprotein A (SpA) at the βH-βI loop, to generate SeMV loop B (SLB), which self-assembled to virus like particles (VLPs) with 43 times higher affinity towards antibodies. CP and SLB could internalize into various types of mammalian cells and SLB could efficiently deliver three different monoclonal antibodies–D6F10 (targeting abrin), anti-α-tubulin (targeting intracellular tubulin) and Herclon (against HER2 receptor) inside the cells. Such a mode of delivery was much more effective than antibodies alone treatment. These results highlight the potential of SLB as a universal nanocarrier for intracellular delivery of antibodies.Keywords
This publication has 49 references indexed in Scilit:
- Mechanistic Insights into the Neutralization of Cytotoxic Abrin by the Monoclonal Antibody D6F10PLOS ONE, 2013
- Interaction of Cowpea Mosaic Virus Nanoparticles with Surface Vimentin and Inflammatory Cells in Atherosclerotic LesionsNanomedicine, 2012
- Sesbania Mosaic Virus (SeMV) Infectious Clone: Possible Mechanism of 3′ and 5′ End Repair and Role of Polyprotein Processing in Viral ReplicationPLOS ONE, 2012
- Cowpea Mosaic Virus Nanoparticles Target Surface Vimentin on Cancer CellsNanomedicine, 2011
- Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In VivoPLOS ONE, 2009
- Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infectionJournal of Neuroimmunology, 2009
- Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface VimentinPLOS Pathogens, 2009
- Therapeutic antibodies: successes, limitations and hopes for the futureBritish Journal of Pharmacology, 2009
- Dye-doped silica nanoparticle labels/protein microarray for detection of protein biomarkersThe Analyst, 2008
- A Neutralizing Antibody to the A Chain of Abrin Inhibits Abrin Toxicity both In Vitro and In VivoClinical and Vaccine Immunology, 2008